Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Equity (2016 - 2025)

CorMedix has reported Return on Equity over the past 13 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Equity at 0.0% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, up 1.0%.
  • Return on Equity reached 0.0% in Q4 2025 per CRMD's latest filing, down from 0.01% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.01% in Q3 2025 and bottomed at 0.01% in Q2 2024.
  • Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.0%.
  • The largest annual shift saw Return on Equity changed 0bps in 2021 before it grew 1bps in 2024.
  • Over 5 years, Return on Equity stood at 0.0% in 2021, then dropped by -17bps to 0.01% in 2022, then dropped by -12bps to 0.01% in 2023, then soared by 103bps to 0.0% in 2024, then surged by 2540bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for CRMD at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.